Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

RICHMOND, Va., May 8 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics (FOB) and biopharmaceuticals, today reported results for the first quarter ended March 31, 2008.

Recent Company Highlights

-- Follow-on Biologics Program

-- Received regulatory approval from the United Kingdom's Medicines and

Healthcare products Regulatory Agency to initiate a clinical trial

for Insmed's most advanced FOB candidate, INS-19 (Granulocyte Colony

Stimulating Factor or G-CSF), a FOB of the FDA-approved product

Neupogen(R), which had U.S. sales of approximately $0.9 billion in

2007;

-- Received and completed questionnaire from the Chairman and Ranking

Member of the U.S. House of Representatives' Subcommittee on Health

on the possible development of legislation to establish a FOB

regulatory pathway and;

-- Participated in two FOB-focused events: the Center for Business

Intelligence's "Evaluate the Legislative, Economic and Scientific

Implications of the Industry Debate on: Biosimilars and Follow-On

Biologics", and the American Enterprise Institute Follow-On

Biologics Program.

-- IPLEX(TM)

-- All sites have been initiated, received Investigational Review Board

approvals and are actively recruiting trial participants in the

Phase 2 clinical trial for IPLEX(TM) in Myotonic Muscular Dystrophy

("MMD"). The trial presently has 50% of the required 60 patients

enrolled and:

-- Received $2.3 million in cost recovery revenue in the first quarter

related to the expanded access program ("EAP") for IPLEX(TM) in

Italy to treat patients with Amyotrophic Lateral Sclerosis ("ALS"),

also known as Lou Gehrig's Disease. The EAP currently includes 20

phys
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, announced today the ... Calgary in conjunction with co-authors from Kyoto University and ... company,s ongoing clinical research using dermal sheath cup (DSC) ... The paper entitled " Hair Follicle Dermal Stem ...
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced a new ... network of more than 20 contributing fertility practices ... access to a national pool of frozen donor ... of Memphis is the only fertility clinic in the ... Dr. William Kutteh , director of Fertility Associates of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), ... promotion of Nick Maroulis, Pharm.D. to the newly created ... , In this position, Dr. Maroulis will continue to ... directors of our multi-site pharmacies as the company expands. ... during that time he has served in many different ...
Breaking Biology Technology:Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... 28 New Contracts Valued at $115.5 Million Signed in ... (Nasdaq: ARAY ), a global leader in the ... quarter and fiscal year,ended June 28, 2008., For ... revenue,of $50.9 million, a 16 percent increase over fourth ...
... its customer-centric business approach., TINLEY PARK, Ill., ... process and automation engineering firm with offices in,Boston ... is changing its,corporate identity to Cascade Solutions., ... "Throughout,our 14 years of serving the needs of ...
... receives Health Canada clearance to treat severe ... dyschromia and wrinkles, MOUNTAIN VIEW, Calif., Aug. 19 ... market leader of aesthetic,laser skin treatments, today announced its ... recent Health Canada Clearance. The Canadian,debut of the Fraxel ...
Cached Biology Technology:Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 2Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 3Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 4Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 5Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 6Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 7Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 8Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008 9Cascade Controls Changes Corporate Identity to Cascade Solutions 2Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing 2Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing 3Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing 4
(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
(Date:12/3/2014)... Dec. 2, 2014   Marvin Test Solutions ... test solutions for military, aerospace, and manufacturing organizations, ... its successful TS-900 PXI semiconductor test platform ... of high-end systems to customers at a fraction ... to traditional ATE. "Our semiconductor ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... An individual,s personality can have a big effect ... while others find novel situations stressful which can be ... discovering that animals are no different. , A ... Environment Department at the University of York has added ...
... international team of scientists, led by the Institute for Ocean ... to determine that groups of dusky sharks ( Carcharhinus obscurus ... different coastal regions across the globe are separate populations of ... exploited for the shark fin trade, which claims tens of ...
... A Philadelphia botanist who has studied rare plants for 50 years, ... for him is finally getting his due, but with a barely ... Dr. Alfred "Ernie" Schuyler, emeritus curator of botany at the ... recently was honored when a colleague discovered a new species of ...
Cached Biology News:Animals have personalities, too 2Scientists can track origin of shark fins using 'zip codes' in their DNA 2Scientists can track origin of shark fins using 'zip codes' in their DNA 3Rare Pennsylvania fungus is named for Philadelphia botanist 2
... Useful for the mechanical harvesting of ... and ensures even contact with the growth ... and 75cm flasks • Individually wrapped • ... Linkage: This CLS number is a new ...
... The MagneGST™ Protein Purification System ... method for the purification of glutathione-S-transferase ... particles (MagneGST™ Particles) are used to ... crude or cleared lysate using either ...
... compact, versatile system that simultaneously harvests and ... microplates into a solid filter supports for ... gamma counter. The FilterMate is ideal for ... as cell proliferation, receptor binding, nucleic acid ...
... screening project: , 384 Individual ... shape-diverse mixtures of 4 (5 uL each) , ... Individual compounds are dissolved in DMSO at ca. ... Supplied in 5 96-well trays. Dilute library with protein ...
Biology Products: